MONTREAL, QUEBEC--(MARKET WIRE)--Aug 7, 2007 -- Ambrilia Biopharma Inc. (Toronto:AMB.TO - News), a biopharmaceutical company developing novel small molecules and peptides to treat infectious diseases and cancer, announced today that it will be hosting a conference call and webcast on Friday, August 10th, at 10:00 AM ET, to discuss the second quarter 2007 financial results and provide an update on its development program.
